If you have asthma that flares without warning, sinus problems that never quite settle, or hay fever that flips on for no clear reason, an unseen mold may be part of the picture. Curvularia lunata is a tropical fungus that drifts through warm, humid air and lives in soil, plants, and damp indoor spaces.
Most people breathe it in without consequence. A small fraction of people develop a true IgE-mediated allergy to it, and in those people the link to worse asthma, more severe nasal symptoms, and certain forms of fungal sinus disease is clear. This test tells you which group you are in.
Curvularia lunata IgE (immunoglobulin E) is an allergy antibody. Your B cells produce it once your immune system has classified Curvularia mold proteins as a threat. The test measures the concentration of this specific antibody in your blood. A higher level means stronger sensitization. A negative or very low level means your immune system has not built a meaningful allergic memory of this mold.
Sensitization is not the same as a guaranteed allergic reaction. It is a marker of immune readiness. Whether a positive result translates into symptoms depends on how much of the mold you encounter, your overall allergic profile, and how reactive your airways are to begin with.
In a cross-sectional study of 9,223 Chinese adults in Singapore and Malaysia, Curvularia lunata sensitization was associated with about 66% higher odds of physician-diagnosed asthma than those who were not sensitized (odds ratio 1.66, 95% CI 1.17 to 2.33).
Sensitization tracked with worse asthma control, not just having asthma. Sensitized asthmatics had about 81% higher odds of recent wheezing, roughly 2.4 times the odds of needing a doctor or specialist visit for asthma, and about twice the odds of an asthma exacerbation event. Most of this evidence comes from skin prick testing, which measures the same Curvularia sensitization in the skin rather than in serum, but the two tests correlate closely and were used together in this cohort.
In the same cohort, Curvularia sensitization was linked to about 69% higher odds of allergic rhinitis (odds ratio 1.69) and was marginally tied to more moderate-to-severe nasal symptoms. Many sensitized people had both asthma and allergic rhinitis at once, fitting the broader pattern in which fungal sensitization marks a tendency toward upper and lower airway disease together.
Curvularia is one of the dematiaceous (dark-pigmented) molds that can drive allergic fungal rhinosinusitis, a chronic sinus condition combining nasal polyps, thick fungal mucus, and an IgE-mediated reaction to the fungus. Diagnostic workups for this condition include serum Curvularia-specific IgE alongside skin testing, total IgE, and imaging.
Case reports describe Curvularia-driven pansinusitis with elevated total and Curvularia-specific IgE and IgG, sometimes extending into the orbit. If you have stubborn sinus symptoms with polyps or thick mucus, a positive Curvularia IgE strengthens the case for evaluation by an ENT (ear, nose, and throat) specialist or allergist familiar with fungal sinus disease.
International guidelines from the ISHAM (International Society for Human and Animal Mycology) ABPA (allergic bronchopulmonary aspergillosis) working group recognize that severe lung disease driven by molds other than Aspergillus, including Curvularia, can produce allergic bronchopulmonary mycosis. Diagnosis requires fungus-specific IgE plus a high total IgE (often defined as 500 IU/mL or higher) and compatible imaging. Custom assays are often needed for non-Aspergillus molds, which is why Curvularia-specific testing is part of the workup in difficult-to-treat asthma.
Curvularia IgE rarely travels alone. In the Singapore and Malaysia cohort, IgE levels against Aspergillus, Penicillium, Cladosporium, and other molds were positively correlated with each other. Aspergillus-specific IgE was the most common positive result, found in roughly 23.6% of those tested in the serum subset, and tracked more closely with allergic rhinitis severity than Curvularia did. A positive Curvularia result usually points to broader fungal sensitization worth mapping out.
These ranges come from a Singapore and Malaysia research cohort of 9,223 Chinese adults using ImmunoCAP-style serum IgE assays. They are illustrative orientation, not a target. Your lab may use slightly different cutpoints or reporting units. Compare results within the same lab over time.
| Class | Range (kU/L) | What It Suggests |
|---|---|---|
| Class 0 | Below 0.10 | No detectable sensitization |
| Class 1 to 2 | 0.10 to 3.49 | Low-level sensitization, often clinically silent |
| Class 3 or higher | 3.50 or above | Sensitization at the level used in research linking Curvularia to asthma and allergic rhinitis risk |
What this means for you: A class 3 or higher result is the threshold researchers used to define meaningful sensitization in the largest available human cohort. Lower-class results may still matter clinically if you have symptoms in mold-rich environments, but they fall below the level where epidemiological associations have been established.
A single positive result tells you that your immune system has built an antibody response to Curvularia. The level can shift over months and years depending on ongoing exposure, allergen-specific immunotherapy, or changes in your overall allergic activity. If you are reducing mold exposure at home or working through a treatment plan, a baseline test followed by retesting in 6 to 12 months gives you a sense of whether your sensitization is stable, growing, or fading.
Lab-to-lab variation in IgE assays is real, so trending within the same lab matters more than comparing absolute numbers between labs. Symptoms can also drift independently of antibody levels. The most informative picture comes from pairing a serial IgE trend with how your asthma, sinus, or hay fever symptoms are actually behaving.
A positive Curvularia IgE is most actionable when paired with the right context. Consider these next steps:
Specific IgE testing is usually less sensitive to short-term factors than blood sugar or hormones, but a few things can still distort interpretation. Acute allergic flares or recent intense exposure to mold may temporarily raise levels. Standardization of fungal extracts is a known weak point in the field, and assays from different labs can give different numbers for the same sample. A negative serum result does not always rule out sensitization, since skin prick testing occasionally picks up reactivity that serum testing misses, and the reverse can also happen.
Curvularia Lunata Mold IgE is best interpreted alongside these tests.